Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
several biotech firms
|
| gptkbp:awards |
industry recognition
|
| gptkbp:CEO |
gptkb:Zhang_Jian
|
| gptkbp:clinicalTrials |
ongoing
|
| gptkbp:collaborations |
academic institutions
|
| gptkbp:employees |
over 1,000
|
| gptkbp:founded |
1997
|
| gptkbp:headquarters |
gptkb:Yiyang,_Hunan,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Yiyang Biopharmaceutical
|
| gptkbp:investmentFocus |
R&D
|
| gptkbp:market |
gptkb:China
|
| gptkbp:partnerships |
various international pharmaceutical companies
|
| gptkbp:patentCitation |
numerous in biopharmaceuticals
|
| gptkbp:products |
vaccines
monoclonal antibodies recombinant proteins |
| gptkbp:regulatoryCompliance |
multiple products
|
| gptkbp:research_focus |
biologics
|
| gptkbp:revenue |
growing annually
|
| gptkbp:specializesIn |
biopharmaceuticals
|
| gptkbp:subsidiary |
gptkb:Yiyang_Pharmaceutical
|
| gptkbp:website |
www.yiyangbio.com
|